Robert Yarchoan
Robert Yarchoan is an American physician and scientist known for his significant contributions to the field of HIV/AIDS research. He is currently the Chief of the HIV and AIDS Malignancy Branch at the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH).
Early Life and Education[edit | edit source]
Robert Yarchoan was born in New York City. He earned his Bachelor of Arts degree from Amherst College and his Doctor of Medicine (M.D.) from the University of Pennsylvania School of Medicine. Following his medical degree, he completed his residency in internal medicine at the University of Minnesota.
Career[edit | edit source]
Yarchoan began his career at the NIH in 1980 as a clinical associate in the National Institute of Allergy and Infectious Diseases (NIAID). He later joined the NCI, where he has spent the majority of his career.
Contributions to HIV/AIDS Research[edit | edit source]
Robert Yarchoan is best known for his pioneering work in the development of antiretroviral therapy for HIV/AIDS. He was part of the team that conducted the first clinical trials of zidovudine (AZT), the first drug approved for the treatment of HIV. His work has been instrumental in the development of other antiretroviral drugs, including didanosine (ddI) and stavudine (d4T).
Leadership Roles[edit | edit source]
In addition to his research, Yarchoan has held several leadership positions within the NIH. He has served as the Chief of the HIV and AIDS Malignancy Branch since its inception. Under his leadership, the branch has made significant advances in understanding and treating HIV-associated malignancies.
Awards and Honors[edit | edit source]
Robert Yarchoan has received numerous awards for his contributions to medical science, including the Arthur S. Flemming Award and the Public Health Service Outstanding Service Medal. He is also a member of the American Society for Clinical Investigation and the Association of American Physicians.
Personal Life[edit | edit source]
Yarchoan is married and has two children. He resides in Maryland.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD